Global Melatonin Market is valued approximately USD 468.77 million in 2020 and is anticipated to grow with a healthy growth rate of more than 7.32% over the forecast period 2021-2027. Melatonin is a hormone that is naturally created in the body and aids in the regulation of the sleep-wake cycle. It is synthesized in a laboratory for the treatment of short-term insomnia. It has antioxidant effects. Melatonin’s market expansion is predicted to be fueled by high demand for nutritional supplements. Increasing consumer health awareness, along with a changing lifestyle, is likely to drive demand. Melatonin market growth is projected to be aided by growth in the food and beverage industry. Melatonin’s market expansion is predicted to be fueled by rising consumer expenditure on food products, as well as rising demand for a variety of food products. According to the United States Department of Agriculture Economic Research Service, food expenditures by consumers, corporations, and government bodies in the United States was valued at $1.77 trillion in 2019. According to The Institute of Food Technologists, sales of naturally healthy foods exceeded $259 billion in February 2020. However, strict governmental laws and restrictions, as melatonin pills are regulated as prescription medications, as well as raw material price fluctuation hampers the growth of the market over the forecast period of 2021-2027. Also, growing number of pharmacies, multi-specialty stores, clinical centres, and diagnostics centres, as well as increased usage of melatonin in the manufacturing of bio-based spray polyurethane foam for construction and building insulation is likely to increase the market growth during the forecast period.
The geographical analysis of global melatonin market is considered for the main regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share attributing to the high use of dietary supplements and SPF in construction activities in the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as rising disposable income, changing lifestyle, rapidly growing prevalence of dietary supplements and growing construction and pharmaceutical sectors would create lucrative growth prospects for the Melatonin market across Asia-Pacific region.
Major market player included in this report are:
Bebida Beverage Co.
Neurim Pharmaceuticals Ltd.
Pulse Pharmaceuticals Pvt. Ltd.
Flynn Pharma Ltd.
Fidia Farmaceutici S.P.A.
Aspen Pharmacare Holdings Ltd.
Schiff Nutrition International Inc.
Solal Technologies (Pty) Ltd.
Rexall Sundown, Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Food & Beverages
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Melatonin Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers